Header

UZH-Logo

Maintenance Infos

Publications for Soltermann, A

Navigate back| Up a level
Export as
Group by:
Number of items: 105.

2018

Brajkovic, Saška; Pelz, Benjamin; Procopio, Maria-Giuseppina; Leblond, Anne-Laure; Repond, Grégoire; Schaub-Clerigué, Ariane; Dupouy, Diego G; Soltermann, Alex (2018). Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma. Diagnostic Pathology, 13:79.

Gulati, Pratiksha; Rühl, Julia; Kannan, Abhilash; Pircher, Magdalena; Schuberth, Petra; Nytko, Katarzyna J; Pruschy, Martin; Sulser, Simon; Haefner, Mark; Jensen, Shawn; Soltermann, Alex; Jungraithmayr, Wolfgang; Eisenring, Maya; Winder, Thomas; Samaras, Panagiotis; Tabor, Annett; Stenger, Rene; Stupp, Roger; Weder, Walter; Renner, Christoph; Münz, Christian; Petrausch, Ulf (2018). Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice. Clinical Cancer Research, 24(16):3981-3993.

Kiessling, Si-Young; Broglie, Martina Anja; Soltermann, Alex; Huber, Gerhard Frank; Stoeckli, Sandro Johannes (2018). Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure. Laryngoscope Investigative Otolaryngology, 3(4):283-289.

Velizheva, Nadezda P; Rechsteiner, Markus P; Valtcheva, Nadejda; Freiberger, Sandra N; Wong, Christine E; Vrugt, Bart; Zhong, Qing; Wagner, Ulrich; Moch, Holger; Hillinger, Sven; Schmitt-Opitz, Isabelle; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2018). Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Pathology, Research and Practice, 214(4):572-578.

George, Julie; Walter, Vonn; Peifer, Martin; et al; Soltermann, A; Weder, W (2018). Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature Communications, 9(1):1048.

Xia, Daniel; Casanova, Ruben; Machiraju, Devayani; McKee, Trevor D; Weder, Walter; Beck, Andrew H; Soltermann, Alex (2018). Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma. Scientific Reports, 8(1):3941.

Letovanec, Igor; Finn, Stephen; Zygoura, Panagiota; Smyth, Paul; et al; Soltermann, Alex; Weder, Walter (2018). Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the ETOP Lungscape Project. Journal of Thoracic Oncology, 13(3):413-425.

Vavricka, Stephan R; Galván, Jose A; Dawson, Heather; Soltermann, Alex; Biedermann, Luc; Scharl, Michael; Schoepfer, Alain M; Rogler, Gerhard; Prinz Vavricka, Mareike B; Terracciano, Luigi; Navarini, Alexander A; Zlobec, Inti; Lugli, Alessandro; Greuter, Thomas (2018). Expression patterns of TNFα, MAdCAM1 and STAT3 in intestinal and skin manifestations of inflammatory bowel disease. Journal of Crohn's & Colitis, 12(3):347-354.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil F; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

2017

Diebold, Matthias; Soltermann, Alex; Hottinger, Selma; Haile, Sarah R; Bubendorf, Lukas; Komminoth, Paul; Jochum, Wolfram; Grobholz, Rainer; Theegarten, Dirk; Berezowska, Sabina; Darwiche, Kaid; Oezkan, Filiz; Kohler, Malcolm; Franzen, Daniel P (2017). Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score - a multicenter study. Respiratory Research, 18(1):210.

Valdec, Silvio; Pasic, Pavla; Soltermann, Alex; Thoma, Daniel; Stadlinger, Bernd; Rücker, Martin (2017). Alveolar ridge preservation with autologous particulated dentin-a case series. International Journal of Implant Dentistry, 3(1):1-9.

De Luca, Roberto; Soltermann, Alex; Pretto, Francesca; Pemberton-Ross, Catherine; Pellegrini, Giovanni; Wulhfard, Sarah; Neri, Dario (2017). Potency-matched dual cytokine-antibody fusion proteins for cancer therapy. Molecular Cancer Therapeutics, 16(11):2442-2451.

Dal Corso, Alberto; Gébleux, Rémy; Murer, Patrizia; Soltermann, Alex; Neri, Dario (2017). A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo. Journal of Controlled Release, 264:211-218.

Broglie, Martina A; Stoeckli, Sandro J; Sauter, Rafael; Pasche, Philippe; Reinhard, Antoine; de Leval, Laurence; Huber, Gerhard F; Pezier, Thomas F; Soltermann, Alex; Giger, Roland; Arnold, Andreas; Dettmer, Matthias; Arnoux, Andre; Müller, Martin; Spreitzer, Stefan; Lang, Florian; Lutchmaya, Mathieu; Stauffer, Edouard; Espeli, Vittoria; Martucci, Francesco; Bongiovanni, Massimo; Foerbs, Diana; Jochum, Wolfram (2017). Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Head and Neck, 39(10):2004-2015.

Malchers, Florian; Ercanoglu, Meryem; Schütte, Daniel; Castiglione, Roberta; Tischler, Verena; Michels, Sebastian; Dahmen, Ilona; Brägelmann, Johannes; Menon, Roopika; Heuckmann, Johannes M; George, Julie; Ansén, Sascha; Sos, Martin L; Soltermann, Alex; Peifer, Martin; Wolf, Jürgen; Büttner, Reinhard; Thomas, Roman K (2017). Mechanisms of primary drug resistance in FGFR1-amplified lung cancer. Clinical Cancer Research, 23(18):5527-5536.

Soltermann, Alex (2017). Ein kleiner Einstieg zu Diagnostik und Prädiktion des Lungenkarzinoms. Therapeutische Umschau. Revue thérapeutique, 74(4):157-164.

Castañón, Eduardo; Soltermann, Alex; López, Inés; Román, Marta; Ecay, Margarita; Collantes, María; Redrado, Miriam; Baraibar, Iosune; López-Picazo, José María; Rolfo, Christian; Vidal-Vanaclocha, Fernando; Raez, Luis; Weder, Walter; Calvo, Alfonso; Gil-Bazo, Ignacio (2017). The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer Letters, 402:43-51.

Gachechiladze, Mariam; Škarda, Josef; Soltermann, Alex; Joerger, Markus (2017). RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies. International Journal of Cancer, 141(7):1286-1294.

Casanova, Ruben; Xia, Daniel; Rulle, Undīne; Nanni, Paolo; Grossmann, Jonas; Vrugt, Bart; Wettstein, Reto; Ballester, Rafael; Astolfo, Alberto; Weder, Walter; Moch, Holger; Stampanoni, Marco; Beck, Andrew H; Soltermann, Alex (2017). Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness. Cancer Research, 77(10):2585-2593.

Brock, Matthias; Hottinger, Selma; Diebold, Matthias; Soltermann, Alex; Jochum, Wolfram; Kohler, Malcolm; Huber, Lars C; Franzen, Daniel P (2017). Low tissue levels of miR-125b predict malignancy in solitary fibrous tumors of the pleura. Respiratory Research, 18(1):1-8.

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Velizheva, Nadezda P; Rechsteiner, Markus P; Wong, Christine E; Zhong, Qing; Rössle, Matthias; Bode, Beata; Moch, Holger; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2017). Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathology, 125(1):30-40.

Gébleux, Rémy; Stringhini, Marco; Casanova, Ruben; Soltermann, Alex; Neri, Dario (2017). Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix. International Journal of Cancer, 140(7):1670-1679.

2016

Leisibach, Priska; Schneiter, Didier; Soltermann, Alex; Yamada, Yoshi; Weder, Walter; Jungraithmayr, Wolfgang (2016). Prognostic value of immunohistochemical markers in malignant thymic epithelial tumors. Journal of Thoracic Disease, 8(9):2580-2591.

Meerang, Mayura; Bérard, Karima; Friess, Martina; Bitanihirwe, Byron K Y; Soltermann, Alex; Vrugt, Bart; Felley-Bosco, Emanuela; Bueno, Raphael; Richards, William G; Seifert, Burkhardt; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Molecular Oncology, 10(8):1255-1265.

Burger, Irene A; Casanova, Ruben; Steiger, Seraina; Husmann, Lars; Stolzmann, Paul; Huellner, Martin W; Curioni, Alessandra; Hillinger, Sven; Schmidtlein, Charles Ross; Soltermann, Alex (2016). FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response. Journal of Nuclear Medicine, 57(6):849-854.

Morand, Grégoire B; Fellmann, Jonas; Laske, Roman D; Weisert, Jan U; Soltermann, Alex; Zbinden, Reinhard; Probst, Rudolf; Huber, Gerhard F (2016). Detection of Helicobacter pylori in head and neck cancer patients: Results from a prospective comparative study combining serology, PCR, and rapid urease test. Head and Neck, 38(5):769-774.

Maquieira, R; Haerle, S K; Huber, G F; Soltermann, A; Haile, S R; Stoeckli, S J; Broglie, Martina A (2016). No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression. European Archives of Oto-Rhino-Laryngology, 273(7):1841-1848.

2015

Frischknecht, Lukas; Meerang, Mayura; Soltermann, Alex; Stahel, Rolf; Moch, Holger; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2015). Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery, 149(6):1539-1547.e1.

Thies, Svenja; Friess, Martina; Frischknecht, Lukas; Korol, Dimitri; Felley-Bosco, Emanuela; Stahel, Rolf; Vrugt, Bart; Weder, Walter; Opitz, Isabelle; Soltermann, Alex (2015). Expression of the stem cell factor nestin in malignant pleural mesothelioma is associated with poor prognosis. PLoS ONE, 10(9):e0139312.

Denoth, Seraina; Broglie, Martina A; Haerle, Stephan K; Huber, Gerhard F; Haile, Sarah R; Soltermann, Alex; Jochum, Wolfram; Stoeckli, Sandro J (2015). Histopathological mapping of metastatic tumor cells in sentinel lymph nodes of oral and oropharyngeal squamous cell carcinomas. Head and Neck, 37(10):1477-1482.

Broglie, Martina A; Soltermann, Alex; Haile, Sarah R; Huber, Gerhard F; Stoeckli, Sandro J (2015). Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy. European Archives of Oto-Rhino-Laryngology, 272(7):1755-1762.

Collaud, Stéphane; Tischler, Verena; Atanassoff, Andrej; Wiedl, Thomas; Komminoth, Paul; Oehlschlegel, Christian; Weder, Walter; Soltermann, Alex (2015). Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN. BMC Cancer, 15(74):online.

2014

Fellmann, Jonas; Weisert, Jan U; Soltermann, Alex; Morand, Grégoire; Morra, Laura; Moch, Holger; Huber, Gerhard F; Probst, Rudolf (2014). Helicobacter pylori detected in pharyngeal and laryngeal pathologies in patients with proven gastric colonization. Head and Neck, 36(11):1562-1566.

von Laffert, Maximilian; Warth, Arne; Penzel, Roland; Schirmacher, Peter; Kerr, Keith M; Elmberger, Göran; Schildhaus, Hans-Ulrich; Büttner, Reinhard; Lopez-Rios, Fernando; Reu, Simone; Kirchner, Thomas; Pauwels, Patrick; Specht, Katja; Drecoll, Enken; Höfler, Heinz; Aust, Daniela; Baretton, Gustavo; Bubendorf, Lukas; Stallmann, Sonja; Fisseler-Eckhoff, Annette; Soltermann, Alex; Tischler, Verena; Moch, Holger; Penault-Llorca, Frederique; Hager, Hendrik; Schäper, Frank; Lenze, Dido; Hummel, Michael; Dietel, Manfred (2014). Multicenter Immunohistochemical ALK-Testing of Non-Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria. Journal of Thoracic Oncology, 9(11):1685-1692.

Darwiche, K; Ozkan, F; Ting, S; Johnen, G; Brüning, T; Soltermann, A; Huber, L C; Christoph, D C; Freitag, L; Franzen, D (2014). Prätherapeutische Biomarker des Lungenkarzinoms unter besonderer Berücksichtigung der Bronchoskopie. Pneumologie (Stuttgart, Germany), 68(11):719-726.

Warth, A; Cortis, J; Soltermann, A; Meister, M; Budczies, J; Stenzinger, A; Goeppert, B; Thomas, M; Herth, F J F; Schirmacher, P; Schnabel, P A; Hoffmann, H; Dienemann, H; Muley, T; Weichert, W (2014). Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. British Journal of Cancer, 111(6):1222-1229.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Franzen, Daniel; Diebold, Matthias; Soltermann, Alex; Schneiter, Didier; Kestenholz, Peter; Stahel, Rolf; Weder, Walter; Kohler, Malcolm (2014). Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulmonary Medicine, 14:138.

Fernandez-Cuesta, Lynnette; Peifer, Martin; Lu, Xin; et al; Soltermann, Alex (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nature Communications, 5:3518.

Inci, Ilhan; Soltermann, Alex; Schneiter, Didier; Weder, Walter (2014). Pulmonary malignant peripheral nerve sheath tumour. European Journal of Cardio-Thoracic Surgery, 46(2):331-332.

2013

Broglie, M A; Soltermann, A; Rohrbach, D; Haile, S R; Pawlita, M; Studer, G; Huber, G F; Moch, H; Stoeckli, S J (2013). Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head and Neck, 35(12):1698-1706.

Warth, Arne; Fink, Ludger; Fisseler-Eckhoff, Annette; Jonigk, Danny; Keller, Marius; Ott, German; Rieker, Ralf J; Sinn, Peter; Söder, Stephan; Soltermann, Alex; Willenbrock, Klaus; Weichert, Wilko (2013). Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Archiv, 462(5):507-513.

Broglie, M A; Soltermann, A; Haile, S R; Röösli, C; Huber, G F; Schmid, S; Stoeckli, S J (2013). Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity. The Laryngoscope, 123(1):164-170.

Schuberth, Petra C; Hagedorn, Christian; Jensen, Shawn M; Gulati, Pratiksha; van den Broek, Maries; Mischo, Axel; Soltermann, Alex; Jüngel, Astrid; Marroquin Belaunzaran, Osiris; Stahel, Rolf; Renner, Christoph; Petrausch, Ulf (2013). Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. Journal of Translational Medicine, 11:187.

2012

Orlowski, Katrin; Rohrer Bley, Carla; Zimmermann, Martina; Vuong, Van; Hug, Daniel; Soltermann, Alexander; Broggini-Tenzer, Angela; Pruschy, Martin (2012). Dynamics of tumor hypoxia in response to patupilone and ionizing radiation. PLoS ONE, (7(12)):e51476.

Petrausch, U; Schuberth, P C; Hagedorn, C; Soltermann, A; Tomaszek, S; Stahel, R; Weder, W; Renner, C (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer, 12:615.

Soltermann, Alex (2012). Epithelial-mesenchymale Transition beim nichtkleinzelligen Bronchialkarzinom. Der Pathologe, 33(Suppl 2):311-317.

Morra, L; Rechsteiner, M; Casagrande, S; von Teichman, A; Schraml, P; Moch, H; Soltermann, A (2012). Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer, 76(2):183-190.

Dietrich, Dimo; Hasinger, Oliver; Liebenberg, Volker; Field, John K; Kristiansen, Glen; Soltermann, Alex (2012). DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non-small-cell Lung Cancer Patients. Diagnostic Molecular Pathology, 21(2):93-104.

von Boehmer, Lotta; Draenert, Alice; Jungraithmayr, Wolfgang; Inci, Ilhan; Niklaus, Schäfer; Boehler, Annette; Hofer, Markus; Stahel, Rolf; Soltermann, Alex; van den Broek, Maries; Weder, Walter; Knuth, Alexander (2012). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer, 76(1):118-122.

Peifer, Martin; Fernández-Cuesta, Lynnette; Sos, Martin L; et al; Soltermann, Alex; Moch, Holger (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics, 44(10):1104-1110.

Bonde, Anne-Katrine; Tischler, Verena; Kumar, Sushil; Soltermann, Alex; Schwendener, Reto (2012). Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer, 12:35.

Petrausch, Ulf; Tischler, Verena; Weder, Walter; Soltermann, Alex (2012). Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer? memo - Magazine of European Medical Oncology, 5(2):154-156.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Leisibach, Priska; Weder, Walter; Soltermann, Alex; Jungraithmayr, Wolfgang (2012). Primary Sclerosing Epithelioid Fibrosarcoma of the Lung in a Patient with Lynch Syndrome. Lung, 190(6):691-695.

Ziegler, A; Cerciello, F; Bigosch, C; Bausch-Fluck, D; Felley-Bosco, E; Ossola, R; Soltermann, A; Stahel, R A; Wollscheid, B (2012). Proteomic surfaceome analysis of mesothelioma. Lung Cancer, 75(2):189-196.

Wulf, Marie-Angela; Bode, Beata; Zimmermann, Dieter; Rufibach, Kaspar; Weder, Walter; Moch, Holger; Soltermann, Alex; Tischler, Verena (2012). Silver-enhanced In Situ Hybridization for Determination of EGFR Copy Number Alterations in Non-Small Cell Lung Cancer. The American journal of surgical pathology, 36(12):1801-1808.

Warth, Arne; Cortis, Judith; Fink, Ludger; Fisseler-Eckhoff, Annette; Geddert, Helene; Hager, Thomas; Junker, Klaus; Kayser, Gian; Kitz, Julia; Länger, Florian; Morresi-Hauf, Alicia; Ott, German; Petersen, Iver; Stenzinger, Albrecht; Soltermann, Alex; Ting, Saskia; Tischler, Verena; Vollmer, Ekkehard; Schnabel, Philipp A; Weichert, Wilko (2012). Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Archiv, 461(2):185-193.

Vorburger, M S; Broglie, M A; Soltermann, Al; Haerle, S K; Haile, S R; Huber, G F; Stoeckli, S J (2012). Validity of frozen section in sentinel lymph node biopsy for the staging in oral and oropharyngeal squamous cell carcinoma. Journal of Surgical Oncology, 106(7):816-819.

2011

Haerle, S K; Strobel, K; Ahmad, N; Soltermann, A; Schmid, D T; Stoeckli, S J (2011). Contrast-enhanced (18)F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head and Neck, 33(3):324-329.

Palumbo, A; Hauler, F; Dziunycz, P; Schwager, K; Soltermann, A; Pretto, F; Alonso, C; Hofbauer, G F; Boyle, R W; Neri, D (2011). A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels. British Journal of Cancer, 104(7):1106-1115.

Wiedl, T; Arni, S; Roschitzki, B; Grossmann, J; Collaud, S; Soltermann, A; Hillinger, S; Aebersold, R; Weder, W (2011). Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. Journal of Proteomics, 74(10):1884-1894.

Felley-Bosco, E; Opitz, I; Soltermann, A; Thies, S; Weder, W; Stahel, R A (2011). Asbestos-induced tissue regeneration and malignant pleural mesothelioma: Insights from developmental studies. In: Berhardt, L V. Advances in Medicine and Biology. Volume 34. Hauppauge NY, USA: Nova Science Publishers, 131-153.

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Soltermann, A; Kilgus-Hawelski, S; Behnke, S; Storz, M; Moch, H; Bode, B (2011). Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10. Journal of Clinical Bioinformatics, 1:25.

Busacca, S; Sheaff, M; Arthur, K; Gray, S G; O'Byrne, K J; Richard, D J; Soltermann, A; Opitz, I; Pass, H; Harkin, D P; Quinn, J E; Fennell, D A (2011). BRCA1 is an essential mediator of vinorelbine induced apoptosis in mesothelioma. Journal of Pathology:1-28.

Shi, Y; Hollenstein, A; Felley-Bosco, E; Fraefel, C; Ackermann, M; Soltermann, A; Weder, W; Stahel, R A; Pruschy, M; Opitz, I (2011). Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer, 71(3):370-371.

Huber, G F; Zullig, L; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Studer, G; Jochum, W; Moch, H; Stoeckli, S J (2011). Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer, 11:217.

Huber, G F; Albinger-Hegyi, A; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Holzmann, D; Moch, H; Hegyi, I (2011). Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer, 117(20):4659-4670.

Wagner, P L; Stiedl, A C; Wilbertz, T; Petersen, K; Scheble, V; Menon, R; Reischl, M; Mikut, R; Rubin, M A; Fend, F; Moch, H; Soltermann, A; Weder, W; Altorki, N K; Perner, S (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer, 74(1):118-123.

Jacobsen, C; Lübbers, H T; Obwegeser, J A; Soltermann, A; Grätz, K W (2011). Histological evaluation of microsurgical revascularized bone in the intraoral cavity: Does it remain alive? Microsurgery, 31(2):98-103.

Sidi, R; Pasello, G; Opitz, I; Soltermann, A; Tutic, M; Rehrauer, H; Weder, W; Stahel, R A; Felley-Bosco, E (2011). Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. European Journal of Cancer, 47(2):326-332.

Draenert, A; Marquardt, K; Inci, I; Soltermann, A; Weder, W; Jungraithmayr, W (2011). Ischaemia-reperfusion injury in orthotopic mouse lung transplants - a scanning electron microscopy study. International Journal of Experimental Pathology, 92(1):18-25.

Tischler, V; Pfeifer, M; Hausladen, S; Schirmer, U; Bonde, A K; Kristiansen, G; Sos, M L; Weder, W; Moch, H; Altevogt, P; Soltermann, A (2011). L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Molecular Cancer, 10:127.

Soltermann, A; Pache, J C; Vogt, P (2011). Metastasis of a pleural mesothelioma to a hyperplastic stomach polyp: an increase of vimentin expression is seen during a gain in deciduoid morphology. Rare Tumors, 3(4):e52.

Hammerman, P S; Sos, M L; Ramos, A H; Xu, C; Dutt, A; Zhou, W; Brace, L E; Woods, B A; Lin, W; Zhang, J; Deng, X; Lim, S M; Heynck, S; Peifer, M; Simard, J R; Lawrence, M S; Onofrio, R C; Salvesen, H B; Seidel, D; Zander, T; Heuckmann, J M; Soltermann, A; Moch, H; Koker, M; Leenders, F; Gabler, F; Querings, S; Ansén, S; Brambilla, E; Brambilla, C; Lorimier, P; Brustugun, O T; Helland, A; Petersen, I; Clement, J H; Groen, H; Timens, W; Sietsma, H; Stoelben, E; Wolf, J; Beer, D G; Tsao, M S; Hanna, M; Hatton, C; Eck, M J; Janne, P A; Johnson, B E; Winckler, W; Greulich, H; Bass, A J; Cho, J; Rauh, D; Gray, N S; Wong, K K; Haura, E B; Thomas, R K; Meyerson, M (2011). Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery, 1(1):78-89.

Frei, C; Opitz, I; Soltermann, A; Fischer, B; Moura, U; Rehrauer, H; Weder, W; Stahel, R; Felley-Bosco, E (2011). Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis, 32(9):1324-1332.

Morra, L; Rechsteiner, M; Casagrande, S; Duc Luu, V; Santimaria, R; Diener, P A; Sulser, T; Kristiansen, G; Schraml, P; Moch, H; Soltermann, A (2011). Relevance of periostin splice variants in renal cell carcinoma. American Journal of Pathology, 179(3):1513-1521.

Maier, S; Wilbertz, T; Braun, M; Scheble, V; Reischl, M; Mikut, R; Menon, R; Nikolov, P; Petersen, K; Beschorner, C; Moch, H; Kakies, C; Protzel, C; Bauer, J; Soltermann, A; Fend, F; Staebler, A; Lengerke, C; Perner, S (2011). SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Human Pathology, 42(8):1078-1088.

Wilbertz, T; Wagner, P; Petersen, K F; Stiedl, A C; Scheble, V J; Maier, S; Reischl, M; Mikut, R; Altorki, N K; Moch, H; Fend, F; Staebler, A; Bass, A J; Meyerson, M; Rubin, M A; Soltermann, A; Lengerke, C; Perner, S (2011). SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Modern Pathology, 24(7):944-953.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

2010

Schramm, A; Opitz, I; Thies, S; Seifert, B; Moch, H; Weder, W; Soltermann, A (2010). Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 37(3):566-572.

Pedretti, M; Rancic, Z; Soltermann, A; Herzog, B A; Schliemann, C; Lachat, Mario L; Neri, D; Kaufmann, P A (2010). Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies. Atherosclerosis, 208(2):382-389.

Bhure, U N; Lardinois, D; Kalff, V; Hany, T F; Soltermann, A; Seifert, Burkhardt; Steinert, H C (2010). Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements. British Journal of Radiology, 83(994):841-849.

Soltermann, A; Opitz, I; Tischler, V; Thies, S; Morra, L; Stahel, R A; Weder, W; Moch, H (2010). EMT in NSCLC and malignant pleural mesothelioma. memo - Magazine of European Medical Oncology, 3(4):180-184.

Soltermann, A. Epithelial-mesenchymal transition in thoracic malignancies. 2010, University of Zurich, Faculty of Medicine.

Riener, M O; Fritzsche, F R; Soll, C; Pestalozzi, B C; Probst-Hensch, N M; Clavien, P A; Jochum, W; Soltermann, A; Moch, H; Kristiansen, G (2010). Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, 56(5):600-606.

Weiss, J; Sos, M L; Seidel, D; et al; Soltermann, A; Moch, H (2010). Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Science Translational Medicine, 2(62):62ra93.

Collaud, S; Wiedl, T; Cattaneo, E; Soltermann, A; Hillinger, S; Weder, W; Arni, S (2010). Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. Journal of Biomolecular Techniques, 21(1):25-28.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

2009

Pedretti, M; Soltermann, A; Arni, S; Weder, W; Neri, D; Hillinger, S (2009). Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 64(1):28-33.

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Ring, B Z; Seitz, R S; Beck, R A; Shasteen, W J; Soltermann, A; Arbogast, S; Robert, F; Schreeder, M T; Ross, D T (2009). A novel five-antibody immunohistochemical test for subclassification of lung carcinoma. Modern Pathology, 22(8):1032-1043.

Huber, L C; Soltermann, A; Fischler, M; Gay, S; Weder, W; Russi, E W; Speich, R; Ulrich, S (2009). Caveolin-1 Expression and Hemodynamics in COPD Patients. Open Respiratory Medicine Journal, 3:73-78.

Soltermann, A; Tischler, V (2009). EGFR-Status beim Lungen-Adeno-Ca. Leading Opinions. Hämatologie & Onkologie, (5):64-66.

Soltermann, A; Moch, H (2009). Klinisch relevante Biomarker des nicht kleinzelligen Lungenkarzinoms. Diagnostik, Prognose, Therapie und Prävention. The Medical Journal (TMJ), 2009(4):26-29.

Perner, S; Wagner, P L; Soltermann, A; LaFargue, C; Tischler, V; Weir, B A; Weder, W; Meyerson, M; Giordano, T J; Moch, H; Rubin, M A (2009). TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. Journal of Pathology, 217(1):65-72.

2008

Soltermann, A; Tischler, V; Arbogast, S; Braun, J; Probst-Hensch, N M; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Perner, Sven; Wagner, Patrick L; Demichelis, Francesca; Mehra, Rohit; LaFargue, Christopher J; Moss, Benjamin J; Arbogast, Stefanie; Soltermann, Alex; Weder, Walter; Giordano, Thomas J; Beer, David G; Rickman, David S; Chinnaiyan, Arul M; Moch, Holger; Rubin, Mark A (2008). EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia, 10(3):298-302.

Schmitt, A M; Riniker, F; Anlauf, M; Schmid, S; Soltermann, A; Moch, H; Heitz, P U; Klöppel, G; Komminoth, P; Perren, A (2008). Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. American Journal of Surgical Pathology, 32(3):420-425.

Soltermann, A; Ossola, R; Kilgus-Hawelski, S; von Eckardstein, A; Suter, T; Aebersold, R; Moch, H (2008). N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer, 114(2):124-133.

Opitz, I; Soltermann, A; Abaecherli, M; Hinterberger, M; Probst-Hensch, N; Stahel, R; Moch, H; Weder, W (2008). PTEN expression is a strong predictor of survival in mesothelioma patients. European Journal of Cardio-Thoracic Surgery, 33(3):502-506.

This list was generated on Tue Dec 18 22:48:48 2018 CET.